BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zakiryanova GK, Wheeler S, Shurin MR. Oncogenes in immune cells as potential therapeutic targets. Immunotargets Ther 2018;7:21-8. [PMID: 29692982 DOI: 10.2147/ITT.S150586] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Salkeni MA, Shin JY, Gulley JL. Resistance to Immunotherapy: Mechanisms and Means for Overcoming. Adv Exp Med Biol 2021;1342:45-80. [PMID: 34972962 DOI: 10.1007/978-3-030-79308-1_2] [Reference Citation Analysis]
2 Øvestad IT, Engesæter B, Halle MK, Akbari S, Bicskei B, Lapin M, Austdal M, Janssen EAM, Krakstad C, Lillesand M, Nordhus M, Munk AC, Gudlaugsson EG. High-Grade Cervical Intraepithelial Neoplasia (CIN) Associates with Increased Proliferation and Attenuated Immune Signaling. Int J Mol Sci 2021;23:373. [PMID: 35008799 DOI: 10.3390/ijms23010373] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
3 Carbajo-García MC, Corachán A, Segura-Benitez M, Monleón J, Escrig J, Faus A, Pellicer A, Cervelló I, Ferrero H. 5-aza-2'-deoxycitidine inhibits cell proliferation, extracellular matrix formation and Wnt/β-catenin pathway in human uterine leiomyomas. Reprod Biol Endocrinol 2021;19:106. [PMID: 34233687 DOI: 10.1186/s12958-021-00790-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
4 Hasan Jasim R, Haider Abdualameer H. CLEC4E as a New Tumor Marker for Early Diagnosis of GIT Tumors. RJPT 2021. [DOI: 10.52711/0974-360x.2021.00552] [Reference Citation Analysis]
5 Sobhani N, Tardiel-Cyril DR, Davtyan A, Generali D, Roudi R, Li Y. CTLA-4 in Regulatory T Cells for Cancer Immunotherapy. Cancers (Basel) 2021;13:1440. [PMID: 33809974 DOI: 10.3390/cancers13061440] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 41.0] [Reference Citation Analysis]
6 Zakiryanova GK, Kustova E, Urazalieva NT, Baimukhametov ET, Makarov VA, Turaly GM, Shurin GV, Biyasheva ZM, Nakisbekov NN, Shurin MR. Notch signaling defects in NK cells in patients with cancer. Cancer Immunol Immunother 2021;70:981-8. [PMID: 33083905 DOI: 10.1007/s00262-020-02763-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Shihab I, Khalil BA, Elemam NM, Hachim IY, Hachim MY, Hamoudi RA, Maghazachi AA. Understanding the Role of Innate Immune Cells and Identifying Genes in Breast Cancer Microenvironment. Cancers (Basel) 2020;12:E2226. [PMID: 32784928 DOI: 10.3390/cancers12082226] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
8 Zakiryanova GK, Kustova E, Urazalieva NT, Baimuchametov ET, Nakisbekov NN, Shurin MR. Abnormal Expression of c-Myc Oncogene in NK Cells in Patients with Cancer. Int J Mol Sci 2019;20:E756. [PMID: 30754645 DOI: 10.3390/ijms20030756] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
9 Tuccitto A, Shahaj E, Vergani E, Ferro S, Huber V, Rodolfo M, Castelli C, Rivoltini L, Vallacchi V. Immunosuppressive circuits in tumor microenvironment and their influence on cancer treatment efficacy. Virchows Arch. 2019;474:407-420. [PMID: 30374798 DOI: 10.1007/s00428-018-2477-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 7.5] [Reference Citation Analysis]